CSL Seqirus says manufacturing setbacks have left Australia with just a few hundred doses of Q-VAX, with normal supplies unlikely to be restored until 2027.
CSL Seqirus says manufacturing setbacks have left Australia with just a few hundred doses of Q-VAX, with normal supplies unlikely to be restored until 2027.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.